Nightingale Health Ltd

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  4. Effective ways to optimise heat exchangers Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
  5. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...

Upcoming event

Lounges

23-25 April 2024 | Conference | Messe Karlsruhe, Germany See all

Related Content

Research & Development

New technology links chronic inflammation to shorter lifespan

Investigating a new marker for chronic inflammation GlycA, researchers have found that chronic inflammation is linked to increased risk for shorter lifespan and several organ-related diseases. The findings were made through investigating GlycA measurements with Nightingale Health’s blood testing technology. The results highlight a potential use for measuring GlycA in healthcare.
Research & Development

Analysis of 0.5 million blood samples to facilitate global medical research

Comprehensive metabolic biomarker profiles of the world's largest health database to be analysed in 30 months
Digital

Nightingale and THL Biobank scheme accelerates personalised medicine

A Finnish company who have developed biomarker testing for chronic disease screening will analyse 40,000 blood samples from THL biobank
Regulatory

Metabolic biomarker profiling agreement for Oxford University

Nightingale Health and Oxford University’s Nuffield Department of Population Health work on metabolic biomarker profiling
Subscribe now